These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1408461)
1. A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus. Murphy M; Hyun W; Hunte B; Levine AD; Epstein LB Pediatr Res; 1992 Sep; 32(3):269-76. PubMed ID: 1408461 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). Murphy M; Friend DS; Pike-Nobile L; Epstein LB J Immunol; 1992 Oct; 149(7):2506-12. PubMed ID: 1388194 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of LFA-1 and ICAM-1 in Down syndrome thymus. Implications for abnormal thymocyte maturation. Murphy M; Insoft RM; Pike-Nobile L; Derbin KS; Epstein LB J Immunol; 1993 Jun; 150(12):5696-703. PubMed ID: 8099939 [TBL] [Abstract][Full Text] [Related]
4. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. Suda T; Murray R; Guidos C; Zlotnik A J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma is produced by activated immature mouse thymocytes and inhibits the interleukin 4-induced proliferation of immature thymocytes. Ransom J; Fischer M; Mosmann T; Yokota T; DeLuca D; Schumacher J; Zlotnik A J Immunol; 1987 Dec; 139(12):4102-8. PubMed ID: 3121729 [TBL] [Abstract][Full Text] [Related]
6. Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts. Iwamoto T; Yamada A; Yuasa K; Fukumoto E; Nakamura T; Fujiwara T; Fukumoto S Arch Oral Biol; 2009 Oct; 54(10):963-9. PubMed ID: 19700144 [TBL] [Abstract][Full Text] [Related]
7. Differential effect of tumour necrosis factor on human thymocyte subpopulations. Muñoz-Fernández MA; Pimentel-Muiños FX; González A; Gambon F; Alvarez-Vallina L; Fresno M Immunology; 1992 Jul; 76(3):439-45. PubMed ID: 1526653 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 production by T cells: a study of the immunoregulatory actions of interferon-alpha, interferon-gamma, and tumor necrosis factor-alpha in phenotypically different T cell clones. Dao T; Holán V; Minowada J Cell Immunol; 1993 Oct; 151(2):451-9. PubMed ID: 8402948 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes. Arend WP; Ammons JT; Kotzin BL J Immunol; 1987 Sep; 139(6):1873-9. PubMed ID: 2957441 [TBL] [Abstract][Full Text] [Related]
10. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Albanesi C; Cavani A; Girolomoni G J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. Thornhill MH; Wellicome SM; Mahiouz DL; Lanchbury JS; Kyan-Aung U; Haskard DO J Immunol; 1991 Jan; 146(2):592-8. PubMed ID: 1702807 [TBL] [Abstract][Full Text] [Related]
12. Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Mingari MC; Maggi E; Cambiaggi A; Annunziato F; Schiavetti F; Manetti R; Moretta L; Romagnani S Eur J Immunol; 1996 May; 26(5):1083-7. PubMed ID: 8647171 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. Takashima T; Ohnishi K; Tsuyuguchi I; Kishimoto S J Immunol; 1993 Apr; 150(7):3002-10. PubMed ID: 8454870 [TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines. Totpal K; Aggarwal BB Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157 [TBL] [Abstract][Full Text] [Related]
15. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. Le JM; Vilcek J J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705 [TBL] [Abstract][Full Text] [Related]
16. Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4. Wood SC; Rao TD; Frey AB Cell Immunol; 1999 Feb; 192(1):1-12. PubMed ID: 10066341 [TBL] [Abstract][Full Text] [Related]
17. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. Zlotnik A; Godfrey DI; Fischer M; Suda T J Immunol; 1992 Aug; 149(4):1211-5. PubMed ID: 1386860 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 differentially modulates interleukin-4- and interleukin-2-induced human B cell growth. Kimata H; Lindley I Eur J Immunol; 1994 Dec; 24(12):3237-40. PubMed ID: 7805753 [TBL] [Abstract][Full Text] [Related]
19. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor. Beresini MH; Lempert MJ; Epstein LB J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746 [TBL] [Abstract][Full Text] [Related]
20. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNF-alpha, IFN-gamma and glucocorticoids. Fayad R; Sennello JA; Kim SH; Pini M; Dinarello CA; Fantuzzi G Eur J Immunol; 2005 Aug; 35(8):2304-12. PubMed ID: 16047339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]